Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05259111 · ClinicalTrials.gov registry record · NA
Home Hospital for Bariatric Sleeve Gastrectomy
A NA study of Bariatric Surgery Candidate and Bariatric Sleeve Gastrectomy, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 2
- Study locations
NCT05259111: Completed NA study of Bariatric Surgery Candidate and Bariatric Sleeve Gastrectomy, sponsored by Brigham and Women's Hospital.
NCT05259111 is a NA study of Bariatric Surgery Candidate and Bariatric Sleeve Gastrectomy that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 28 participants, below the 112-participant average among 28 other Bariatric Surgery Candidate trials with a reported enrollment target (75% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05259111, a NA study of Bariatric Surgery Candidate and Bariatric Sleeve Gastrectomy, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 2
- Study locations
Study Summary
Providing acute care at home for medicine patients is a well-studied care model. Providing acute care at home immediately following major surgery is less well understood. The investigators seek to demonstrate the noninferiority of care at home versus the hospital for patients undergoing bariatric sleeve gastrectomy.
Primary Outcome
Days spent hospitalized
Conditions Studied
Interventions
- OTHER Home hospital
Study Locations (2)
Massachusetts
- Brigham and Women's Faulkner Hospital - Boston
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2022-02-23 |
| Est. Completion | 2024-05-24 |
| Phase | NA |
What the finished NCT05259111 record still lists
NCT05259111 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 112-participant average among 28 other Bariatric Surgery Candidate trials with a reported enrollment target (75% lower).
The record links to 3 conditions, with Bariatric Surgery Candidate appearing as the primary indexed condition, and to 1 intervention - of which Home hospital is the first listed.
NCT05259111 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05259111 about?
NCT05259111 is a clinical study titled "Home Hospital for Bariatric Sleeve Gastrectomy". Providing acute care at home for medicine patients is a well-studied care model. Providing acute care at home immediately following major surgery is less well understood. The investigators seek to demonstrate the noninferiority of care at home versus the hospital for patients undergoing bariatric sl...
What is the current status of trial NCT05259111?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2022-02-23. Estimated completion is 2024-05-24.
What conditions does trial NCT05259111 study?
This clinical trial studies the following conditions: Bariatric Surgery Candidate, Bariatric Sleeve Gastrectomy, Home Hospital.
What interventions are being tested in trial NCT05259111?
The interventions under investigation include: Home hospital (OTHER).
Who is sponsoring clinical trial NCT05259111?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05259111 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bariatric Surgery Candidate
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05259111's enrollment target sits among peer trials
28 24th of 28 higher than 4 of 28 other Bariatric Surgery Candidate trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bariatric Surgery Candidate trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gut Microbiome and Sex as Risk Factors for Kidney Stones After Bariatric Surgery
RECRUITING · NA
-
GI Oxalate Absorption
RECRUITING · NA
-
Effects of Assisted Robotic vs Laparoscopic Sleeve Gastrectomy
RECRUITING · NA
-
Exercise, Brain Activity, and Weight Maintenance
RECRUITING · NA
-
RemI for Post-Bariatric Surgery Weight Regain
RECRUITING · NA
-
Postoperative VR for Recovery After Bariatric Surgery
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI